India  

COVID vaccine distribution requires funding of Rs 80,000 crore, says Serum Institute of India

DNA Saturday, 19 December 2020
Serum Institute-Oxford's Covishield, Bharat Biotech's Covaxin and Pfizer vaccine are in the fray for emergency use authorization.
0
shares
ShareTweetSavePostSend
 
Video Credit: HT Digital Content - Published
News video: How to ensure vaccine reaches every Indian? SII’s Adar Poonawalla answers

How to ensure vaccine reaches every Indian? SII’s Adar Poonawalla answers 01:53

As India inches closer towards a Covid vaccine, Serum Institute of India CEO Adar Poonawalla spoke on the challenge of vaccinating every Indian. Poonawalla said that many private players should be brought in to partner with the government and their distribution networks will surely help. He added...

You Might Like


💡 newsR Knowledge: Other News Mentions

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

Republic Day: Security measures tightened in anticipation of terror threat

Due to the COVID pandemic, no foreign guest will be present at India's Republic Day parade,
DNA
UP records 404 new COVID cases, 666 recoveries in last 24 hours [Video]

UP records 404 new COVID cases, 666 recoveries in last 24 hours

Uttar Pradesh Additional Chief Secretary, Health, Amit Mohan Prasad on January 17 informed about the current situation of the state. He said that as many as 404 new COVID-19 cases have been recorded in the state in past 24 hours. Whereas, 666 people have been discharged in the same duration. Active cases in the state are 8881 in which 3210 people are in home isolation.

Credit: ANI    Duration: 01:17Published

More than half of over-80s have received COVID vaccine as 140 jabs given a minute

More than half of over-80s have received at least one dose of a coronavirus vaccine, as the government has revealed that 140 jabs are being given out a minute. 
Sky News

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Covid vaccine: How many Indians got jab on Day 1? Govt reveals [Video]

Covid vaccine: How many Indians got jab on Day 1? Govt reveals

At least 1,65,714 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi. About 16,755 total vaccinators involved across India during the COVID vaccination drive. There was no post adverse event reported after the vaccination was administered to the people. "Total vaccinators involved across India were 16,755. Total beneficiaries vaccinated across India--1,65,714. COVID19 vaccination drive was successful on Day 1. No case of post-vaccination hospitalisation reported so far," said Manohar Agnani, Additional Secretary of Union Health Ministry. "The Serum Institute of India (SII) produced COVISHIELD was supplied to all States and Union Territories (UT). Bharat Biotech's COVAXIN was supplied to 12 States. Total 3,351 sessions were held across the country with both the vaccines, said Health Ministry on COVID19 vaccine roll-out," he added. Watch the full video for more details.

Credit: HT Digital Content    Duration: 06:46Published
First feeling, side-effects, doubts: Vaccinated doctors share experience [Video]

First feeling, side-effects, doubts: Vaccinated doctors share experience

On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made Covishield jabs respectively. Both didn't experience any side-effects and said that doubts regarding the inoculants are unfounded. Dr Suranjit Chatterjee of Apollo hospital, who is set to receive a shot soon, also weighed in on the controversy regarding Covaxin and its third phase trials. Watch the full video for more.

Credit: HT Digital Content    Duration: 08:15Published
Nepal: People cheers after approval of Covishield vaccine manufactured in India [Video]

Nepal: People cheers after approval of Covishield vaccine manufactured in India

After Nepal government approved emergency use of Covishield vaccine, people are hoping the pandemic will falter and human lives would be back on track. Nepal's Department of Drug Administration on Friday issued a release giving information on approving Covishield developed by AstraZeneca and Oxford University, which will be manufactured by Serum Institute of India (SII) in India. Drug regulating authority has also specified Serum Institute of India for importers provided with low cost in purchasing and delivery of vaccine to public. Approving the vaccine for conditional purpose, the department has also asked manufacturers or importers to get approval for registration in order to bring the vaccines. Nepal imposed nationwide and partial lockdown for most of 2020 with rise in imported cases which later took the form of local transmission spreading mostly in urban areas and major cities. The nationwide lockdown which started in March 2020 hampered daily life of people as well as businesses. They now expect to thrive with the approval of vaccine. Though the detailed inoculation plan of Nepal Government is yet to be disclosed, a total of 3 companies applied for approval to take steps forward with Serum Institute for import of vaccines. India has already made conditional emergency approval for Covishield manufactured by the Serum Institute. Being one of the largest producers of vaccines at low cost, India has promised to provide vaccine to its neighbours in near future.

Credit: ANI    Duration: 02:39Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine [Video]

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine

Urging the people to have faith in India's researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria on Saturday reassured the nation that Bharat Biotech's COVAXIN vaccine is safe. Dr Guleria along with NITI Aayog member VK Paul were administered the COVID-19 vaccine shot at AIIMS Delhi on the inaugural day of the nationwide roll-out of vaccination on Saturday. Talking about the experience, he said, "I am humbled to get vaccinated in the first slot and feel so proud. I hope more and more people come forward when it comes to getting vaccinated so that we can reduce mortality and prevent the spread of COVID-19 infection." Dr VK Paul said that the vaccine is safe and people should trust the scientific process. Watch the full video for more details.

Credit: HT Digital Content    Duration: 03:41Published

Pfizer Pfizer Multinational pharmaceutical corporation

Phase 3 trial of Pfizer, Moderna underway, benefits are overwhelming compared to risk: VK Paul [Video]

Phase 3 trial of Pfizer, Moderna underway, benefits are overwhelming compared to risk: VK Paul

NITI Aayog Member (Health) Dr VK Paul said that phase 3 trial of Pfizer, Moderna is still going on but the benefits are overwhelming compared to risk. "World has decided to move forward, take benefit and ensure what's needed in this stage," he said. "Safety proven without doubt on thousands and thousands of individuals. We should respect the scientific processes that unfolded in extremely different, difficult and unusual circumstances. Today, 2 great vaccines are available. Whatever vaccine you're allotted, please take it," he added.

Credit: ANI    Duration: 01:14Published
COVID vaccines: Six EU countries hit out at 'unacceptable' delays to deliveries of Pfizer jab [Video]

COVID vaccines: Six EU countries hit out at 'unacceptable' delays to deliveries of Pfizer jab

"Fewer doses will be available for European countries at the end of January and the beginning of February," said Pfizer.

Credit: Euronews English    Duration: 03:40Published

Pfizer to cut COVID vaccine deliveries as it upgrades production facility

Pfizer has confirmed it is planning to temporarily slow deliveries of its coronavirus vaccine to Europe while it focuses on upscaling its manufacturing..
Sky News

Related videos from verified sources

CM Biren Singh launches vaccination drive at JNIMS in Manipur [Video]

CM Biren Singh launches vaccination drive at JNIMS in Manipur

Manipur Chief Minister N Biren Singh launched COVID-19 vaccination at Jawaharlal Nehru Institute of Medical Sciences on January 16. He reviewed the COVID-19 vaccine administration at the hospital. In..

Credit: ANI     Duration: 01:09Published
Watch: SII CEO Poonawalla receives shot of Covishield vaccine [Video]

Watch: SII CEO Poonawalla receives shot of Covishield vaccine

Serum Institute of India (SII), CEO Adar Poonawalla received a COVISHIELD vaccine shot on January 16. COVISHIELD vaccine is manufactured by SII. India has approved 2 vaccines - Covishield and Covaxin...

Credit: ANI     Duration: 01:08Published
'Janta curfew, lockdown…': PM Modi recalls India's early steps to tackle Covid [Video]

'Janta curfew, lockdown…': PM Modi recalls India's early steps to tackle Covid

Prime Minister Narendra Modi on Saturday launched India's COVID-19 vaccination drive and asserted that the made-in-India vaccines being rolled out will ensure a "decisive victory" for the country over..

Credit: HT Digital Content     Duration: 06:14Published

Related news from verified sources

China's COVID-19 vaccine is caught in controversy

China has been projecting itself as the front-runner in the Covid vaccine race but has now gone in for a deal to buy the Pfizer BioNtech vaccine from Germany for...
Mid-Day Also reported by •IndiaTimesHinduDNA

Europe to decide on safety of BioNTech, Pfizer vaccine on December 29

The European Medicines Agency said on Tuesday it will convene a meeting on December 29 to decide if there is enough data about the safety and efficacy of the...
Mid-Day Also reported by •HinduIndian Express

Pfizer becomes first pharma company in India to seek emergency use nod for its Covid-19 vaccine

Pfizer India has become the first pharmaceutical firm to approach the Drugs Controller General of India (DCGI) seeking an emergency use authorisation for its...
IndiaTimes